CN Patent

CN111479591A — 治疗戈谢病的方法

Assigned to Genzyme Corp · Expires 2020-07-31 · 6y expired

What this patent protects

用于治疗具有肾损伤或肝损伤的患者中的戈谢病的方法。

USPTO Abstract

用于治疗具有肾损伤或肝损伤的患者中的戈谢病的方法。

Drugs covered by this patent

eliglustat-tartrate (ELIGLUSTAT TARTRATE)

Patent Metadata

Patent number: CN111479591A
Jurisdiction: CN
Classification: —
Expires: 2020-07-31
Drug substance claim: No
Drug product claim: No
Assignee: Genzyme Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.